Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis
Shu Feng(University of Southern California), Alexander I. Agoulnik(Florida International University), Thomas Klonisch(CancerCare Manitoba), Irina U. Agoulnik(University of South Florida), Hee Dong Han(IMEC), Anne Truong(Baylor College of Medicine), Chad J. Creighton(Baylor College of Medicine), R.M. Pereira(Florida International University), Michael Ittmann(Baylor College of Medicine), Zhen Li(Tongji Hospital), Gabriel Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The Ohio State University Wexner Medical Center), Elena M. Kaftanovskaya(Florida International University)
Cited by 82
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k